Keating (and Robin Williams in Dead Poets’ Society) said ‘I stand upon my desk to remind yourself that we must constantly look at things in a different way,' said Lauralyn McDaniel, AMSC Vice Chair, Medical Industry Manager at SME, adding, “That is what the regenerative medicine industry must do to progress.”
Manufacturing has long been central to global economies and prosperity, creating value and opportunity for communities, workers and their families. The Society of Manufacturing Engineers (SME), which traces its history back to the 1930s, was created as a membership organization but has grown beyond that to serve the manufacturing industry even more broadly with events, workforce development and media products.
SME is currently aligned, and is a part of, over 50% of the Manufacturing USA Institutes and was also a part of the Department of Defense (DoD) development on the proposals for several of the new institutes.
“The SME Additive Manufacturing/3D Printing (AM/3DP) community is a large and diverse group; but it is a community that comes together with others to help speed up processes. For example this is where medical can learn from aerospace, automotive, consumer goods, and others and in turn, can share lessons learned with aerospace, automotive, and more. We constantly need fresh eyes on the challenges,” McDaniel continued.
SME is committed to promoting manufacturing technology for Regenerative Medicine, developing a skilled workforce and attracting future generations to the industry. Building on an expertise by working with the 3D printing community since 1990, SME brings a unique perspective and network of experts that include many already involved in tissue fabrication.
“SME comes to Regenerative Manufacturing from the AM/3DP side,” said McDaniel. “We have had a leadership position with the 3D printing community since the technology was called rapid prototyping. Members of the SME AM/3DP community have developed methods for printing scaffolds and other devices for regenerative medicine.”
As one of fastest-growing AM/3DP application areas, more growth is expected for biomedical/medical applications. More than 97 percent of medical AM/3DP professionals expect the use and applications in Regenerative Medicine to continue to grow (See SME Medical AM/3DP Survey, December 2017).
“The Medical AM/3DP Workgroup, which had its roots in 2003 in a tech group, supports those using AM/3DP technologies for medical and biomedical applications,” said McDaniel. “Of our 200,000 AM/3DP community members, over 80,000 represent a varied group of medical device manufacturers, clinicians, technology providers and others.”
McDaniel feels SME can assist BioFabUSA in the Educational Workforce Development (EWD) area by introducing competency models and a body of codified knowledge to grow the talent pipeline in Regenerative Medicine.
SME has developed an Additive Manufacturing Certification that began as a certificate program in 2003. A collaboration between Tooling U-SME and UL was recently announced to create a single source for professional additive manufacturing certification. This certification combines UL’s multi-tiered training program and Tooling U-SME’s professional certification and input from more than 500 additive manufacturing professionals. The certification is for individuals working in or seeking to work in additive manufacturing roles in automotive, aerospace, and medical equipment. It is also ideal for high schools and colleges as a capstone or standalone achievement to increase workforce readiness in additive manufacturing. Learn more here.
SME has been a facilitator in the standards arena since 2008 – when they approached ASTM to help develop standards for additive manufacturing leading to the creation of ASTM F42 Committee. SME also supports the Additive Manufacturing Standardization Roadmap of America makes and ANSI.
“The Standards Roadmap for the Additive Manufacturing was released in February 2017 through active contribution from more than 200 volunteers and several Standards Development Organizations (SDOs). The second version of the roadmap is scheduled to be published by the end of June 2018,” Mc Daniel said, adding, “SME is excited to collaborate with BioFabUSA members and leverage its relationships, assets and capabilities to help accelerate the standards process.”
To learn more about SME, please visit the website here.